Saturday July 20, 2019
Home India HC imposes Rs...

HC imposes Rs.10 lakh fine on Ram Gopal Verma for remaking ‘Sholay’

0
//
RGV
www.desimartni.com

New Delhi: The Delhi High Court on Monday imposed a fine of Rs.10 lakh on film maker Ram Gopal Varma and his production house for making the remake of 1975 blockbuster ‘Sholay’, which violated the exclusive copyright vested with its director Ramesh Sippy. Justice Manmohan Singh said that Varma and others by making “Ram Gopal Varma ke Sholay: have “intentionally and deliberately” brought the movie in violation of plaintiffs’ exclusive moral rights of copyright. The court’s order came on a lawsuit filed by Sascha Sippy, son and grandson of original Sholay’s producers Vijay Sippy and G.P. Sippy, alleging that remake was violative of exclusive copyright held by the Sholay Media and Entertainment Pvt Ltd.

The court slapped a fine of Rs.10 lakh as “punitive damages” on Varma, his production house M/S RGV Productions Pvt Ltd as well as Varma Corporation Ltd and Madhu Varma and restrained them from using any character like “Gabbar or Gabbar Singh” in the original film. “The publicity material coupled with the impugned film, gives an overall impression that it is a remake of the film ‘Sholay’,” the order said. “The use of similar plot and characters in the impugned film coupled with use of the underlying music, lyrics and background score and even dialogues from the original film ‘Sholay’ amounts to infringement of copyright in the film ‘Sholay’. “The 1975 blockbuster featured Dharmendra, Amitabh Bachchan, Sanjeev Kumar, Hema Malini, Jaya Bachchan and Amjad Khan among others

(IANS)

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)